NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy
Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
Pharmabiz4h
Novo Nordisk and Valo Health expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...
thedailyupside23h
AI Wants to be the Future of Drug Discovery
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
pharmaphorum23h
AMD shadows NVIDIA with a move into AI drug discovery
The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...
GlobalData on MSN20h
ScreenPoint acquires Biomediq to bolster breast cancer risk assessment tool
With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...
The Australian Financial Review9h
Ramsay Health Care Limited
To own and operate hospitals and health care services in over 530 locations across Australia and globally.
Rugbypass21h
Rugby News
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...